ロード中...
A pan-coronavirus fusion inhibitor targeting the HR1 domain of human coronavirus spike
Continuously emerging highly pathogenic human coronaviruses (HCoVs) remain a major threat to human health, as illustrated in past SARS-CoV and MERS-CoV outbreaks. The development of a drug with broad-spectrum HCoV inhibitory activity would address this urgent unmet medical need. Although previous st...
保存先:
| 出版年: | Sci Adv |
|---|---|
| 主要な著者: | , , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
American Association for the Advancement of Science
2019
|
| 主題: | |
| オンライン・アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6457931/ https://ncbi.nlm.nih.gov/pubmed/30989115 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/sciadv.aav4580 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|